No Data
On April 16, JACOBIO-B (01167.HK) spent 0.267 million HKD to repurchase 0.0861 million shares.
Gelonghui announced on April 16 that JACOBIO-B (01167.HK) spent 0.267 million Hong Kong dollars to buy back 0.0861 million shares on April 16.
Biomedical stocks fell across the board, with VIVA BIOTECH (01873) down 27.54%. The impact of China Securities Co.,Ltd.'s tariff policy on the Industry Chain of pharmaceuticals still has uncertainties.
Jinwu Finance | Biomedical stocks fell across the board, with VIVA BIOTECH (01873) down 27.54%, HBM HOLDINGS-B (02142) down 25.43%, CUTIA-B (02487) down 25.13%, Yiming Angke-B (01541) down 24.73%, CSTONE PHARMA-B (02616) down 24.68%, LAEKNA-B (02105) down 24.38%, WUXI BIO (02269) down 24.02%, JACOBIO-B (01167) down 23.72%, and WUXI XDC (02268) down 23.45%. According to multiple sources.
Hong Kong stocks movement | JACOBIO-B (01167) rose more than 10% again. Institutions indicate that the company's cash reserves are sufficient to support over 4 years of operation. Gorey Laces expects to be approved soon.
JACOBIO-B (01167) has risen more than 10% again, as of the time of this report, rising 10.88%, priced at 3.77 HKD, with a transaction volume of 18.0078 million HKD.
Jacobio Pharmaceuticals Group Co., Ltd.'s (HKG:1167) Shares Climb 115% But Its Business Is Yet to Catch Up
Express News | Jacobio Pharma Announces 2024 Annual Results
Press Release: Jacobio Pharma Announces 2024 Annual Results
